SUNY University at Albany: NIH-Funded Cancer Drug Delivery Platform Continues Through Clinical Trials
March 28, 2025
March 28, 2025
ALBANY, New York, March 28 -- SUNY University at Albany issued the following news:
* * *
NIH-Funded Cancer Drug Delivery Platform Continues Through Clinical Trials
By Erin Frick
ALBANY, N.Y. (March 27, 2025) -- For over a decade, University at Albany chemist Max Royzen has been collaborating with San Francisco-based biotech company Shasqi to develop an innovative drug delivery platform that aims to improve targeted cancer treatment while reduci . . .
* * *
NIH-Funded Cancer Drug Delivery Platform Continues Through Clinical Trials
By Erin Frick
ALBANY, N.Y. (March 27, 2025) -- For over a decade, University at Albany chemist Max Royzen has been collaborating with San Francisco-based biotech company Shasqi to develop an innovative drug delivery platform that aims to improve targeted cancer treatment while reduci . . .